Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open, Single-Arm Phase II Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer Expressing the Estrogen and/or Progesterone Receptor

NCT00210028 is registered in ClinicalTrials.gov with Institut Claudius Regaud as lead sponsor.

NCT NCT00210028
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00210028 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open, Single-Arm Phase II Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer Expressing the Estrogen and/or Progesterone Receptor
Lead sponsor
Institut Claudius Regaud
Phase
Phase 2
Overall status
Terminated
Start date
August 31, 2003
Completion date
August 31, 2008
Enrollment
40
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms